Central nervous system involvement in haematological malignancies.

Area of Science:

• Hematology
• Oncology
• Neurology

Background:

• Central nervous system (CNS) involvement is a critical complication in patients with hematologic malignancies.
• Understanding the patterns and outcomes of CNS disease is essential for effective patient management.

Purpose of the Study:

• To review the experience of CNS involvement in patients with lymphoma and acute leukaemia.
• To evaluate the frequency, characteristics, and prognostic implications of CNS disease in different hematologic malignancies.

Main Methods:

• Retrospective review of 540 patients with lymphoma or acute leukaemia treated between 1979 and 1987.
• Analysis of CNS involvement patterns, including type, location, and timing relative to systemic disease.

Main Results:

• CNS involvement was significant in acute lymphoblastic leukaemia and aggressive non-Hodgkin's lymphoma (NHL).
• Leptomeningeal disease in aggressive NHL often occurred during systemic remission and carried a poor prognosis.
• CNS involvement in Hodgkin's disease and low-grade NHL was uncommon and did not significantly impact prognosis.

Conclusions:

• Routine CNS prophylaxis may not be justified for acute non-lymphoblastic leukaemia or low-grade lymphomas.
• CNS prophylaxis might be beneficial for patients with aggressive NHL, particularly given the poor prognosis of leptomeningeal disease.
• Further investigation into CNS prophylaxis strategies for aggressive NHL is warranted.